Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Aobuli, Xieraili"'
Autor:
Rani Pallavi, Elena Gatti, Tiphanie Durfort, Massimo Stendardo, Roberto Ravasio, Tommaso Leonardi, Paolo Falvo, Bruno Achutti Duso, Simona Punzi, Aobuli Xieraili, Andrea Polazzi, Doriana Verrelli, Deborah Trastulli, Simona Ronzoni, Simone Frascolla, Giulia Perticari, Mohamed Elgendy, Mario Varasi, Emanuela Colombo, Marco Giorgio, Luisa Lanfrancone, Saverio Minucci, Luca Mazzarella, Pier Giuseppe Pelicci
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract Caloric Restriction (CR) has established anti-cancer effects, but its clinical relevance and molecular mechanism remain largely undefined. Here, we investigate CR’s impact on several mouse models of Acute Myeloid Leukemias, including Acute
Externí odkaz:
https://doaj.org/article/8f7683b064194aa894f4ffe6b6a13e8b
Publikováno v:
Cancers; Dec2024, Vol. 16 Issue 23, p3993, 19p
Autor:
Santoro, Angela, Vlachou, Thalia, Luzi, Lucilla, Melloni, Giorgio, Mazzarella, Luca, D’Elia, Errico, Aobuli, Xieraili, Pasi, Cristina Elisabetta, Reavie, Linsey, Bonetti, Paola, Punzi, Simona, Casoli, Lucia, Sabò, Arianna, Moroni, Maria Cristina, Dellino, Gaetano Ivan, Amati, Bruno, Nicassio, Francesco, Lanfrancone, Luisa, Pelicci, Pier Giuseppe
Publikováno v:
In Cell Reports 15 January 2019 26(3):624-638
Autor:
Denis Imbody, Hitendra S. Solanki, Bina Desai, Paul A. Stewart, Yaakov Stern, Ryoji Kato, Anurima Majumder, Liznair Bridenstine, Aobuli Xieraili, Bin Fang, Lancia Darville, Fumi Kinose, John M. Koomen, Uwe Rix, Andriy Marusyk, Eric B. Haura
Publikováno v:
Molecular Cancer Research. 21:B015-B015
Purpose: Sotorasib (AMG510) has demonstrated remarkable response in lung cancer patients with tumors driven by oncogenic KRASG12C mutation. However, recently published clinical data identified acquired mutations in RAS and other genomic alterations a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::476c155c5a9ee537a2e9058bbcaa62d8
https://doi.org/10.1158/1557-3125.ras23-b015
https://doi.org/10.1158/1557-3125.ras23-b015
Publikováno v:
Cancer Research. 82:B029-B029
Despite the development of effective targeted agents for the treatment of cancer, targeted therapies eventually fail in advanced, metastatic non-small cell lung cancer (NSCLC) as tumors acquire resistance. Historically, acquired therapy resistance ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdb24af7ec777fb9ecb29f3d15283ffa
https://doi.org/10.1158/1538-7445.evodyn22-b029
https://doi.org/10.1158/1538-7445.evodyn22-b029
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.